Lifecore biomedical announces pending change of auditor and provides expectation for business update

Chaska, minn., march 26, 2024 (globe newswire) --  lifecore biomedical, inc. (nasdaq: lfcr) (“lifecore” or the “company”), a fully integrated contract development and manufacturing organization (“cdmo”), announced today that ernst & young llp, the company's independent registered public accounting firm for the fiscal year ended may 28, 2023, determined that it declined to stand for reappointment as the company's independent registered public accounting firm for the company's fiscal year ending may 26, 2024 following the filing of the company's annual report on form 10-k. lifecore's board of directors has initiated a search for a replacement.
LFCR Ratings Summary
LFCR Quant Ranking